| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1300062 | 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-11-04 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1300035 | 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-07-22 | 嘉和生物药业有限公司 | Genor Biopharma Co Ltd | Certificate Issued | 2016-03-28 | view |
| CXSL1500023 | 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-05-08 | 北京东方百泰生物科技有限公司 | Beijing Dongfang Biotech Co Ltd | Certificate Issued | 2017-02-13 | view |